RENAISSANCE TECHNOLOGIES LLC
Position in INO — Inovio Pharmaceuticals, Inc.
CIK 1037389
NEW YORK, NY
Position in INO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$397,472
-$722,699 QoQ
Shares Held
361,339
-43.9% QoQ
Ownership
0.349%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 101 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. INO ranks #224 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in INO
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $397,472 | 361,339 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,120,171 | 643,777 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $962,505 | 553,164 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,910,233 | 816,339 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $669,383 | 328,129 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $74,699 | 45,828 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $443,418 | 242,305 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,913,561 | 331,066 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,317,373 | 410,566 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $6,249,692 | 450,266 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $3,721,663 | 7,297,379 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,906,904 | 4,889,500 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,446,326 | 5,436,281 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,165,045 | 2,640,300 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,013,099 | 2,572,500 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,020,000 | 2,323,700 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,729,074 | 1,577,500 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,414,032 | 393,881 | Shares | Sole | 2022-05-13 | |
| 2020-03-31 | $4,487,235 | 603,123 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||